An Automated Cancer Organoid Culture Platform to Accelerate Research and Drug Screening

Поділитися
Вставка
  • Опубліковано 30 лип 2024
  • Presented By: Brooke Schuster
    Speaker Biography: Brooke completed a BS in Integrative Biology Honors and Chemistry at the University of Illinois Urbana-Champaign (UIUC) in 2014, graduating with high distinction and honors. During her undergraduate career, Brooke's first experience with cell culture was working with equine (horse) stem cells at University of Illinois School of Veterinary Medicine.
    Webinar: An Automated Cancer Organoid Culture Platform to Accelerate Research and Drug Screening
    Webinar Abstract: Traditionally, high-throughput microfluidics and other similar technologies have relied on two-dimensional (2D) cell models for the study of various human conditions and diseases, yet they are not compatible with 3D culture. Brooke will discuss the development of an automatic and dynamic microfluidic ex vivo organoid culture modeling system to facilitate and accelerate preclinical research and the development of personalized treatment strategies.
    Earn PACE Credits:
    1. Make sure you’re a registered member of LabRoots (www.LabRoots.com)
    2. Watch the webinar on UA-cam or on the LabRoots Website (www.LabRoots.com)
    3. Click Here to get your PACE credits (Expiration date - 1/30/2022): www.labroots.com/credit/pace-...
    LabRoots on Social:
    Facebook: / labrootsinc
    Twitter: / labroots
    LinkedIn: / labroots
    Instagram: / labrootsinc
    Pinterest: / labroots
    SnapChat: labroots_inc
  • Наука та технологія

КОМЕНТАРІ • 1

  • @shaheenshah4294
    @shaheenshah4294 4 роки тому

    How does one account for the role of other factors like microbiota in the treatment of related diseases -how much would the organ and its subsystems would differ from the response seen with just the organoids given drugs dynamically, and/or in combination?